These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
504 related items for PubMed ID: 32141561
1. MicroRNA-29b promotes cell sensitivity to Temozolomide by targeting STAT3 in glioma. Xu JX, Yang Y, Zhang X, Luan XP. Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1922-1931. PubMed ID: 32141561 [Abstract] [Full Text] [Related]
2. miR-519a enhances chemosensitivity and promotes autophagy in glioblastoma by targeting STAT3/Bcl2 signaling pathway. Li H, Chen L, Li JJ, Zhou Q, Huang A, Liu WW, Wang K, Gao L, Qi ST, Lu YT. J Hematol Oncol; 2018 May 29; 11(1):70. PubMed ID: 29843746 [Abstract] [Full Text] [Related]
3. Circ-VPS18 Knockdown Enhances TMZ Sensitivity and Inhibits Glioma Progression by MiR-370/RUNX1 Axis. Li W, Ma Q, Liu Q, Yan P, Wang X, Jia X. J Mol Neurosci; 2021 Jun 29; 71(6):1234-1244. PubMed ID: 33188501 [Abstract] [Full Text] [Related]
4. NCK1-AS1 Increases Drug Resistance of Glioma Cells to Temozolomide by Modulating miR-137/TRIM24. Chen M, Cheng Y, Yuan Z, Wang F, Yang L, Zhao H. Cancer Biother Radiopharm; 2020 Mar 29; 35(2):101-108. PubMed ID: 31750728 [Abstract] [Full Text] [Related]
5. MSC-AS1 knockdown inhibits cell growth and temozolomide resistance by regulating miR-373-3p/CPEB4 axis in glioma through PI3K/Akt pathway. Li C, Feng S, Chen L. Mol Cell Biochem; 2021 Feb 29; 476(2):699-713. PubMed ID: 33106913 [Abstract] [Full Text] [Related]
6. The miR-26a/AP-2α/Nanog signaling axis mediates stem cell self-renewal and temozolomide resistance in glioma. Huang W, Zhong Z, Luo C, Xiao Y, Li L, Zhang X, Yang L, Xiao K, Ning Y, Chen L, Liu Q, Hu X, Zhang J, Ding X, Xiang S. Theranostics; 2019 Feb 29; 9(19):5497-5516. PubMed ID: 31534499 [Abstract] [Full Text] [Related]
7. MiR-181b-5p modulates chemosensitivity of glioma cells to temozolomide by targeting Bcl-2. Zhang X, Yu J, Zhao C, Ren H, Yuan Z, Zhang B, Zhuang J, Wang J, Feng B. Biomed Pharmacother; 2019 Jan 29; 109():2192-2202. PubMed ID: 30551476 [Abstract] [Full Text] [Related]
8. Micro-RNA29b enhances the sensitivity of glioblastoma multiforme cells to temozolomide by promoting autophagy. Xu JX, Yang Y, Zhang X, Luan XP. Anat Rec (Hoboken); 2021 Feb 29; 304(2):342-352. PubMed ID: 32275350 [Abstract] [Full Text] [Related]
9. Mechanisms for hypoxia-induced long non-coding small nucleolar RNA host gene 14 in promoting temozolomide resistance of glioma. Zhao H, Meng L, Liao X, Liu Y, Mo X, Gong M, Liao Y. Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Jul 28; 47(7):829-838. PubMed ID: 36039578 [Abstract] [Full Text] [Related]
10. miR-1297 sensitizes glioma cells to temozolomide (TMZ) treatment through targeting adrenomedullin (ADM). He Z, Cheng M, Hu J, Liu L, Liu P, Chen L, Cao D, Tang J. J Transl Med; 2022 Oct 01; 20(1):443. PubMed ID: 36183123 [Abstract] [Full Text] [Related]
11. MiR-21 protected human glioblastoma U87MG cells from chemotherapeutic drug temozolomide induced apoptosis by decreasing Bax/Bcl-2 ratio and caspase-3 activity. Shi L, Chen J, Yang J, Pan T, Zhang S, Wang Z. Brain Res; 2010 Sep 17; 1352():255-64. PubMed ID: 20633539 [Abstract] [Full Text] [Related]
12. MicroRNA-302c enhances the chemosensitivity of human glioma cells to temozolomide by suppressing P-gp expression. Wu Y, Yao Y, Yun Y, Wang M, Zhu R. Biosci Rep; 2019 Sep 30; 39(9):. PubMed ID: 31409725 [Abstract] [Full Text] [Related]
13. Knockdown of circHIPK3 Facilitates Temozolomide Sensitivity in Glioma by Regulating Cellular Behaviors Through miR-524-5p/KIF2A-Mediated PI3K/AKT Pathway. Yin H, Cui X. Cancer Biother Radiopharm; 2021 Sep 30; 36(7):556-567. PubMed ID: 32833501 [Abstract] [Full Text] [Related]
14. MicoRNA-214-3p: a key player in CPLX2-mediated inhibition on temozolomide resistance in glioma. Peng Q, Wang L, Wang S, Wang C, Xue Z. Neurol Res; 2022 Oct 30; 44(10):879-887. PubMed ID: 36117461 [Abstract] [Full Text] [Related]
15. MiR-136 modulates glioma cell sensitivity to temozolomide by targeting astrocyte elevated gene-1. Wu H, Liu Q, Cai T, Chen YD, Liao F, Wang ZF. Diagn Pathol; 2014 Sep 30; 9():173. PubMed ID: 25266957 [Abstract] [Full Text] [Related]
16. Warburg effect-promoted exosomal circ_0072083 releasing up-regulates NANGO expression through multiple pathways and enhances temozolomide resistance in glioma. Ding C, Yi X, Chen X, Wu Z, You H, Chen X, Zhang G, Sun Y, Bu X, Wu X, Lin Z, Gu J, Lin Y, Kang D. J Exp Clin Cancer Res; 2021 May 11; 40(1):164. PubMed ID: 33975615 [Abstract] [Full Text] [Related]
17. Bortezomib inhibits growth and sensitizes glioma to temozolomide (TMZ) via down-regulating the FOXM1-Survivin axis. Tang JH, Yang L, Chen JX, Li QR, Zhu LR, Xu QF, Huang GH, Zhang ZX, Xiang Y, Du L, Zhou Z, Lv SQ. Cancer Commun (Lond); 2019 Dec 03; 39(1):81. PubMed ID: 31796105 [Abstract] [Full Text] [Related]
18. Upregulation of CASC2 sensitized glioma to temozolomide cytotoxicity through autophagy inhibition by sponging miR-193a-5p and regulating mTOR expression. Jiang C, Shen F, Du J, Fang X, Li X, Su J, Wang X, Huang X, Liu Z. Biomed Pharmacother; 2018 Jan 03; 97():844-850. PubMed ID: 29136760 [Abstract] [Full Text] [Related]
19. DNMT1 mediates chemosensitivity by reducing methylation of miRNA-20a promoter in glioma cells. Zhou D, Wan Y, Xie D, Wang Y, Wei J, Yan Q, Lu P, Mo L, Xie J, Yang S, Qi X. Exp Mol Med; 2015 Sep 04; 47(9):e182. PubMed ID: 26337869 [Abstract] [Full Text] [Related]
20. Exosomal circ-HIPK3 Facilitates Tumor Progression and Temozolomide Resistance by Regulating miR-421/ZIC5 Axis in Glioma. Han C, Wang S, Wang H, Zhang J. Cancer Biother Radiopharm; 2021 Sep 04; 36(7):537-548. PubMed ID: 32644821 [Abstract] [Full Text] [Related] Page: [Next] [New Search]